BRUSSELS - The European Commission on Thursday said it had fined five pharmaceutical companies for a total of 13.4 million euros in a settlement of an antitrust investigation.
The commission fined Alkaloids of Australia, Alkaloids Corporation, Boehringer, Linnea and Transo-Pharm for participating in a cartel aimed at fixing the minimum price of an ingredient to produce the abdominal antispasmodic drug Buscopan and its generic versions.
United States United States Latest News, United States United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
U.S. Treasury bond ETFs draw net inflows this year despite recent market routExplore stories from Atlantic Canada.
Read more »
Planemakers bet on steady demand for business jets, but Wall Street waryExplore stories from Atlantic Canada.
Read more »
EU securities watchdog warns investors over crypto market protectionsExplore stories from Atlantic Canada.
Read more »